This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Watanabe, T. Articles by Arakawa, M. Search for Related Content PubMed Articles by Watanabe, T. Articles by Arakawa, M. Social Bookmarking                   What's this?

Neuropsychiatric manifestations in patients with systemic lupus erythematosus: Diagnostic and predictive value of longitudinal examination of anti-ribosomal P antibody

Department of Medicine () Niigata University School of Medicine

T. Sato

Department of Medicine () Niigata University School of Medicine

T. Uchiumi

Department of Biochemistry, Niigata University School of Medicine, 1-757 Asahimachi-Dori, Niigata 951, Japan

M. Arakawa

Department of Medicine () Niigata University School of Medicine

Anti-ribosomal P (anti-P) antibodies (IgG, IgA, IgM) were measured by an enzyme-linked immunosorbent assay (ELISA) in serial serum samples from the patients with systemic lupus erythematosus (SLE), and these clinical significance was investigated. Neuropsychi atric manifestations were observed in 24 of 144 patients with SLE. Twelve patients had lupus psychosis, nine convulsion or coma and three primary schizophrenia. In the group with lupus psychosis, serum C3 was significantly higher (p < 0.05) and anti-ds-DNA anti body was significantly lower (p < 0.05) than in the other patients. The titer of anti-P anti bodies was significantly higher in the group with lupus psychosis than that of the other patients. In a longitudinal study, IgA and IgM classes of anti-P antibody were elevated at the onset of psychosis. The titer decreased following a remission of psychosis. Therefore, the measurement of immunoglobulin classes of anti-P antibody will be useful for the diagnosis and follow-up of patients with lupus psychosis.

Key Words: SLE • neuropsychiatric manifestation • anti-P antibody • ELISA • longitudinal study

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				T Ebert, J Chapman, and Y Shoenfeld Anti-ribosomal P-protein and its role in psychiatric manifestations of systemic lupus erythematosus: myth or reality? Lupus, August 1, 2005; 14(8): 571 - 575. [Abstract] [PDF]

				R. Gerli, L. Caponi, A. Tincani, R. Scorza, M. G. Sabbadini, M. G. Danieli, V. De Angelis, M. Cesarotti, M. Piccirilli, R. Quartesan, et al. Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients Rheumatology, December 1, 2002; 41(12): 1357 - 1366. [Abstract] [Full Text] [PDF]

				L Massardo, P Burgos, M E Martinez, R Perez, M Calvo, J Barros, A Gonzalez, and S Jacobelli Antiribosomal P protein antibodies in Chilean SLE patients: no association with renal disease Lupus, June 1, 2002; 11(6): 379 - 383. [Abstract] [PDF]

				A Ghirardello, A Doria, S Zampieri, R Gerli, E Rapizzi, and P F Gambari Anti-ribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: their specificity for SLE and association with IgG anticardiolipin antibodies Ann Rheum Dis, December 1, 2000; 59(12): 975 - 981. [Abstract] [Full Text]

				G Sanna, M Piga, J W Terryberry, M T Peltz, S Giagheddu, L Satta, A Ahmed, A Cauli, C Montaldo, G Passiu, et al. Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations Lupus, October 1, 2000; 9(8): 573 - 583. [Abstract] [PDF]

				W. Egner The use of laboratory tests in the diagnosis of SLE J. Clin. Pathol., June 1, 2000; 53(6): 424 - 432. [Full Text] [PDF]

				G. Iverson Are Antibodies to Ribosomal P Proteins a Clinically Useful Predictor of Neuropsychiatric Manifestations in Patients with Systemic Lupus Erythematosus? Lupus, December 1, 1996; 5(6): 634 - 635. [PDF]

				D. Mevorach and K. Elkon Neuropsychiatric lupus: getting beyond the barrier of the brain Lupus, June 1, 1996; 5(3): 173 - 174. [PDF]